Lavipharm SA (FWB:BXA0) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Anastasios Spyropoulos | Chief Manufacturing & Operations Officer · Since at least Sep 3, 2026 |
| Artemis Papadaki | Chief Commercial Officer Hellas · Since at least Nov 5, 2026 |
| Christos Diamandopoulos | Non-Executive Board Member · Since at least Nov 5, 2026 |
| Efi Douni | Marketing Director Rx · Since at least Nov 5, 2026 |
| Eleana Nikolopoulou | Director of Legal & Compliance · Since at least Nov 4, 2026 |
| Emmanouil Petrou | Head of Medical Affairs · Since at least Nov 5, 2026 |
| Ilias Konstantopoulos | Director of Marketing & Sales CHC · Since at least Nov 5, 2026 |
| Ioannis Sarigiannidis | Chief Commercial Officer International · Since at least Nov 5, 2026 |
| James Christopoulos | Independent, Non-Executive Board Member · Since at least Nov 5, 2026 |
| Katerina Karapa | Chief Quality Officer · Since at least Jun 11, 2026 |
| Konstantinos Rengis | Non-Executive Board Member · Since at least Nov 5, 2026 |
| Ligia Panaitescu | Director of Research & Development · Since at least Nov 5, 2026 |
| Loukia Lavida | Board Vice President · Since at least Nov 5, 2026 |
| Mariza Antonaki | Chief People & Technology Officer · Since at least Nov 5, 2026 |
| Nikos Ladas | Chief Scientific Officer · Since at least Nov 5, 2026 |
| Panagiotis Giannouleas | Deputy Chief Executive Officer · Since at least Nov 5, 2026 |
| Roxani Skartsiouni | Director of Supply Chain & Planning · Since at least Nov 5, 2026 |
| Sofia Kounenaki Efraimoglou | Chairperson of the Board · Since at least Nov 5, 2026 |
| Telemaque Jean Lavidas | Chief Executive Officer · Since at least Jan 23, 2025 |
| Vassilis Baloumis | Chief Financial Officer · Since at least Sep 18, 2025 |
| Vicky D. Kefalas | Independent, Non-Executive Board Member · Since at least Nov 4, 2026 |
| Vivienne Thomas | Lead Corporate Communications · Since at least Sep 3, 2026 |